Copyright
©The Author(s) 2025.
World J Diabetes. Jul 15, 2025; 16(7): 104970
Published online Jul 15, 2025. doi: 10.4239/wjd.v16.i7.104970
Published online Jul 15, 2025. doi: 10.4239/wjd.v16.i7.104970
Table 3 Susceptibility test results of 53 strains of Gram-negative bacteria
Drug | Resistant | Intermediate | Susceptible | |||
Number of bacterial strains | Resistance rate | Number of bacterial strains | Resistance rate | Number of bacterial strains | Susceptibility rate | |
Cefazolin | 50 | 94.3 | 3 | 5.7 | 0 | 0 |
Cefepime | 3 | 5.7 | 1 | 1.9 | 49 | 92.4 |
Ceftazidime | 2 | 3.8 | 2 | 3.8 | 49 | 92.4 |
Cefoperazone | 4 | 7.5 | 8 | 15.1 | 41 | 77.4 |
Gentamycin | 37 | 69.8 | 3 | 5.7 | 13 | 24.5 |
Ampicillin | 27 | 50.9 | 2 | 3.8 | 24 | 45.3 |
Amikacin | 6 | 11.3 | 0 | 0.0 | 47 | 88.7 |
Imipenem | 0 | 0.0 | 0 | 0.0 | 53 | 100.0 |
Aztreonam | 21 | 39.6 | 4 | 7.5 | 28 | 52.9 |
Meropenem | 3 | 5.7 | 0 | 0.0 | 50 | 94.3 |
Piperacillin | 22 | 41.5 | 0 | 0.0 | 31 | 58.5 |
- Citation: Liu X, Wang QQ, Qiao SY, Zhu XN. Analysis of nasal secretion culture results in diabetic patients with chronic rhinosinusitis and factors influencing postoperative recurrence. World J Diabetes 2025; 16(7): 104970
- URL: https://www.wjgnet.com/1948-9358/full/v16/i7/104970.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i7.104970